The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice
-
Published:2024-11
Issue:
Volume:89
Page:102019
-
ISSN:2212-8778
-
Container-title:Molecular Metabolism
-
language:en
-
Short-container-title:Molecular Metabolism
Author:
Forny Germano Leticia,
Koehler Jacqueline A.,
Baggio Laurie L.,
Cui Fiona,
Wong Chi Kin,
Rittig Nikolaj,
Cao Xiemin,
Matthews Dianne,
Drucker Daniel J.ORCID
Funder
Novo Nordisk AS
CIHR